Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
ELTP
$0.28
-2.61%
ELTP
· Elite Pharmaceuticals Inc /Nv/
$0.28
-0.01 (-2.61%)
At close · Sep 1
Going-concern doubt
— flagged Jun 29, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In certain years prior to the fiscal year ended March 31, 2021, the auditor's opinion on our financial statements was qualified with respect to there being substantial doubt as to the Company's ability to continue as a going concern due to continued losses not being sufficiently offset by operating revenues.”View the 10-K filed Jun 29, 2026
Market Cap
$302.68M
Shares
1.08B
All earnings calls
Earnings call · FY2020 Q4
Elite Pharmaceuticals Inc (ELTP) Q4 2020 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$4.95M
+268% YoY
Gross margin · derived Q4
49.7%
+10.0 pp YoY
Net income · derived Q4
$936,368
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jun 29, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Jun 29, 2020 · complete as-filed document